Cite

HARVARD Citation

    Nagy, C. et al. (2017). Animal‐to‐Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule. Clinical and translational science. 10 (1), pp. 12-19. [Online]. 
  
Back to record